Dialog window

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
      • Natural Health Products
      • Topical OTC Drugs
      • Medical Devices
      • Consumer Products
      • FDA Consulting
      • Veterinary Health Product
    • Health Canada Consultants
      • Regulatory Affairs
      • Pharmacovigilance Services
      • MoCRA
      • Ingredient Compliance
      • CEPA
      • Good Manufacturing Practices (GMP) Training
      • Technology
  • Innovation
  • Articles
  • Contact
Select Page
Louisiana moves to ease cosmetic requirements for cottage businesses

Louisiana moves to ease cosmetic requirements for cottage businesses

by Srishti Chaudhari | Sep 9, 2026 | Cosmetics, U.S. Regulatory, U.S. State Updates

Louisiana is proposing changes to its cosmetic regulations that would eliminate the state product registration requirement for cosmetics and create a new exemption for qualifying cottage cosmetic facilities. Under the proposed legislation, businesses operating from a...
New Mexico PFAS Protection Act: Cosmetics Restrictions Begin in 2028

New Mexico PFAS Protection Act: Cosmetics Restrictions Begin in 2028

by Srishti Chaudhari | Sep 9, 2026 | U.S. Regulatory, U.S. State Updates

New Mexico’s PFAS Protection Act (HB 212) introduces a phased ban on consumer products containing intentionally added PFAS. For the cosmetics industry, restrictions on cosmetics will take effect January 1, 2028, unless an exemption or currently unavoidable use...
FDA Announces FY 2027 OMUFA User Fee Rates and Streamlines Fee process

FDA Announces FY 2027 OMUFA User Fee Rates and Streamlines Fee process

by Srishti Chaudhari | Sep 9, 2026 | FDA, OTC Drugs, U.S. Regulatory

The USFDA has announced the FY 2027 user fee rates under the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA) with significant increases in facility fees compared with FY 2026. FeeFY 2026FY 2027Monograph Drug Facility (MDF)$19,188$47,891Contract...
US Federal: No PFAS in Cosmetics Act Introduced

US Federal: No PFAS in Cosmetics Act Introduced

by Srishti Chaudhari | Sep 9, 2026 | Cosmetics, FDA, U.S. Regulatory

A bipartisan group of US representatives has introduced HR 9594, the No PFAS in Cosmetics Act, which would amend the Federal Food, Drug, and Cosmetic Act to ban intentionally added PFAS in cosmetics. The bill defines intentionally added PFAS broadly to include PFAS...
Illinois enacts restrictions on certain chemicals in cosmetics

Illinois enacts restrictions on certain chemicals in cosmetics

by Srishti Chaudhari | Sep 9, 2026 | Cosmetics, U.S. Regulatory, U.S. State Updates

Illinois has enacted HB 3409, the Chemicals in Cosmetics Products Act, introducing restrictions on certain intentionally added chemicals in cosmetics sold, manufactured, delivered, held or offered for sale in the state. The law was signed by the Governor on July 10,...
« Older Entries

Recent Posts

  • ICCR: E-labelling and Digital Information General Principles
  • Upcoming Deadlines for Minnesota’s PFAS Reporting
  • Virginia Enacts Ingredient Restrictions (HB 122)
  • Rhode Island Enacts PFAS Ban on Covered Products
  • Maryland Enacts Ingredient Restrictions for Cosmetics and Hair Care

Recent Comments

    Archives

    • September 2026
    • August 2026
    • June 2026
    • April 2026
    • February 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • June 2025
    • May 2025
    • March 2025
    • October 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • December 2023
    • November 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • January 2023
    • December 2022
    • November 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • California Cosmetic Regulations
    • California Office of Environmental Health Hazard Assessment
    • Canadian Environmental Protection Act
    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetic Ingredient Hotlist
    • Cosmetics
    • Cosmetics
    • Environment and Climate Change Canada
    • European Regulatory
    • Events/Company Updates
    • FDA
    • Federal Plastics Registry
    • Health Canada Updates
    • Importation of NHPs
    • Industry Insight
    • Innovation
    • Medical Device
    • Medical Devices
    • MoCRA
    • Natural Health Products
    • New Mexico
    • OTC Drugs
    • Our View
    • Prop 65
    • Research/Science/Technology
    • Toxic-Free Cosmetics Act
    • U.S. Regulatory
    • U.S. State Updates
    • Uncategorized
    Copyright © 2025 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY